Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 69Carcinoma, Non-Small-Cell Lung 60Stomach Neoplasms 32Prostatic Neoplasms 21Nasopharyngeal Carcinoma 20Lung Neoplasms 20Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 10Neoplasm Metastasis 8Head and Neck Neoplasms 7Inflammatory Breast Neoplasms 6Pancreatic Neoplasms 5Neoplasms 5HER2-positive Breast Cancer 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4NSCLC 4Carcinoma, Squamous Cell 4Adenocarcinoma 4Sarcoma 3Nasopharyngeal Neoplasms 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Ovarian Epithelial 3Breast Diseases 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Squamous Cell Lung Cancer 2

Interventions

Bupivacaine 4Analgesia 4Ropivacaine 3Morphine 3Ketamine 3Sufentanil 2Psychiatric Rehabilitation 2Oxycodone 2Methadone 2Lidocaine 2Ketorolac 2Hydromorphone 2Fentanyl 2Esketamine 2Epinephrine 2Docetaxel 2Dexmedetomidine 2Control Groups 2Acetaminophen 2ziconotide 1tanezumab 1parecoxib 1nabiximols 1loxoprofen 1Whole Body Imaging 1Vertebroplasty 1Tramadol 1Therapeutics 1Telemedicine 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Pain × Docetaxel × Clear all
NCT00005960 2013-12-04

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
Genitourinary

Pain, Prostatic Neoplasms

NCT00796458 2013-08-12

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡